
SafetyNet Health Economics Webinar: Evaluating the Cost-Effectiveness of ASSIP
The SafetyNet Health Economics Working Group is delighted to invite you to its upcoming webinar:
A Cost-Effectiveness Estimation of the Attempted Suicide Short Intervention Programme (ASSIP): An economic evaluation of a targeted intervention for individuals at high risk of repeat suicide attempts in Flanders
Date: 22 June 2026
Time: 1 – 2:30pm
Where: Online (MS Teams)
This seminar will present findings from a recent economic evaluation of the Attempted Suicide Short Intervention Programme (ASSIP) in Flanders. The study examined whether ASSIP offers good value for money compared with treatment as usual for people who have previously attempted suicide, using a long-term model to estimate costs and health outcomes over 20 years.
The findings suggest that ASSIP has the potential to improve outcomes while also representing good value, appearing cost-saving from a societal perspective and cost-effective from a healthcare perspective, even in scenarios where its effectiveness reduces over time. The seminar will discuss the implications of these findings for mental health care investment and service planning.
Meet the speaker:
Dr Max Lelie
Vrije Universiteit Brussel
Dr Max Lelie is a health economist and postdoctoral researcher at the Vrije Universiteit Brussel. He holds a PhD in Health Economics from VUB, where his work focused on the design of mathematical models for health economic evaluation, with particular attention to population screening.
During his doctoral research, he contributed to several applied policy projects, including the Helppfl programme, where he was involved in a series of health economic evaluations of mental health interventions. In parallel, he developed and applied modelling approaches to cancer screening, focusing on cost-effectiveness, epidemiological consistency, and broader societal impacts. He is currently a full-time postdoctoral researcher at the Vrije Universiteit Brussel.
NIHR SafetyNet Health Economics Working Group
This working group brings together experts from diverse backgrounds, including patients and the public, to address complex challenges at the intersection of economics and patient safety research.
0 Comments